insights_auto
Outlook: 80.0% bullish·0.0% bearish
Go to analysischevron_right
BBIO:NASDAQ
BridgeBio Pharma Inc
$66.96
arrow_upward
+1.24%(+0.82) 1D
$66.91
arrow_downward
-0.07% (-0.050)todayPre-market
Closed: Oct 6, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BBIO...
Open
$67.75
High
$68.12
Low
$65.70
Mkt. cap
13.31B
Avg. vol.
2.54M
Volume
1.90K
52-wk high
$93.42
52-wk low
$52.75
EPS
-$3.57
Beta
0.97
Shares outstanding
195.49M
No. of employees
1K
Open
$67.75
High
$68.12
Low
$65.70
Mkt. cap
13.31B
Avg. vol.
2.54M
Volume
1.90K
52-wk high
$93.42
52-wk low
$52.75
EPS
-$3.57
Beta
0.97
Shares outstanding
195.49M
No. of employees
1K
News stories
From web sources and news partners
Investing.com
·
1 hour ago
H.C. Wainwright reiterates BridgeBio stock rating on FDA filing
Investing.com
·
1 hour ago
BridgeBio Pharma stock rating reiterated at Buy by Canaccord
Simply Wall Street
·
9 hours ago
Will Priority Review Change BridgeBio Pharma Stock Narrative
AD HOC NEWS
·
14 hours ago
BridgeBio Pharma stock gains 1.24 percent after FDA review news
About BridgeBio Pharma Inc
CEONeil Kumar
Employees1K
Founded2015
HeadquartersPalo Alto, California, United States
SectorBiotechnology
Websitebridgebio.com